Literature DB >> 27811232

Mobility of "HSPG-bound" LPL explains how LPL is able to reach GPIHBP1 on capillaries.

Christopher M Allan1, Mikael Larsson1, Rachel S Jung1, Michael Ploug2, André Bensadoun3, Anne P Beigneux1, Loren G Fong4, Stephen G Young4,5.   

Abstract

In mice lacking glycosylphosphatidylinositol-anchored high density lipoprotein binding protein 1 (GPIHBP1), the LPL secreted by adipocytes and myocytes remains bound to heparan sulfate proteoglycans (HSPGs) on all cells within tissues. That observation raises a perplexing issue: Why isn't the freshly secreted LPL in wild-type mice captured by the same HSPGs, thereby preventing LPL from reaching GPIHBP1 on capillaries? We hypothesized that LPL-HSPG interactions are transient, allowing the LPL to detach and move to GPIHBP1 on capillaries. Indeed, we found that LPL detaches from HSPGs on cultured cells and moves to: 1) soluble GPIHBP1 in the cell culture medium; 2) GPIHBP1-coated agarose beads; and 3) nearby GPIHBP1-expressing cells. Movement of HSPG-bound LPL to GPIHBP1 did not occur when GPIHBP1 contained a Ly6 domain missense mutation (W109S), but was almost normal when GPIHBP1's acidic domain was mutated. To test the mobility of HSPG-bound LPL in vivo, we injected GPIHBP1-coated agarose beads into the brown adipose tissue of GPIHBP1-deficient mice. LPL moved quickly from HSPGs on adipocytes to GPIHBP1-coated beads, thereby depleting LPL stores on the surface of adipocytes. We conclude that HSPG-bound LPL in the interstitial spaces of tissues is mobile, allowing the LPL to move to GPIHBP1 on endothelial cells.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  chylomicrons; endothelial cells; glycosylphosphatidylinositol-anchored high density lipoprotein binding protein 1; heparan sulfate proteoglycan; lipids/chemistry; lipolysis and fatty acid metabolism; lipoprotein lipase; triglycerides

Mesh:

Substances:

Year:  2016        PMID: 27811232      PMCID: PMC5234724          DOI: 10.1194/jlr.M072520

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  40 in total

1.  Idiopathic hyperlipemia: metabolic studies in an affected family.

Authors:  R J HAVEL; R S GORDON
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

2.  Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart.

Authors:  E D KORN
Journal:  J Biol Chem       Date:  1955-07       Impact factor: 5.157

3.  Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil.

Authors:  E D KORN
Journal:  J Biol Chem       Date:  1955-07       Impact factor: 5.157

4.  A new tagging system for production of recombinant proteins in Drosophila S2 cells using the third domain of the urokinase receptor.

Authors:  Henrik Gårdsvoll; Line V Hansen; Thomas J D Jørgensen; Michael Ploug
Journal:  Protein Expr Purif       Date:  2006-12-02       Impact factor: 1.650

5.  Contribution of the carboxy-terminal domain of lipoprotein lipase to interaction with heparin and lipoproteins.

Authors:  A Lookene; M S Nielsen; J Gliemann; G Olivecrona
Journal:  Biochem Biophys Res Commun       Date:  2000-04-29       Impact factor: 3.575

6.  Maturation of lipoprotein lipase in the endoplasmic reticulum. Concurrent formation of functional dimers and inactive aggregates.

Authors:  Osnat Ben-Zeev; Hui Z Mao; Mark H Doolittle
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

7.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.

Authors:  Anne P Beigneux; Brandon S J Davies; Peter Gin; Michael M Weinstein; Emily Farber; Xin Qiao; Franklin Peale; Stuart Bunting; Rosemary L Walzem; Jinny S Wong; William S Blaner; Zhi-Ming Ding; Kristan Melford; Nuttaporn Wongsiriroj; Xiao Shu; Fred de Sauvage; Robert O Ryan; Loren G Fong; André Bensadoun; Stephen G Young
Journal:  Cell Metab       Date:  2007-04       Impact factor: 27.287

Review 8.  Lipoprotein lipase: genetics, lipid uptake, and regulation.

Authors:  Martin Merkel; Robert H Eckel; Ira J Goldberg
Journal:  J Lipid Res       Date:  2002-12       Impact factor: 5.922

9.  Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity.

Authors:  M A Nugent; E R Edelman
Journal:  Biochemistry       Date:  1992-09-22       Impact factor: 3.162

10.  Interaction of lipoprotein lipase and receptor-associated protein.

Authors:  Shallee Page; Andrea Judson; Kristan Melford; André Bensadoun
Journal:  J Biol Chem       Date:  2006-03-03       Impact factor: 5.157

View more
  17 in total

Review 1.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

2.  Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders.

Authors:  Marco Bruno Morelli; Christopher Chavez; Gaetano Santulli
Journal:  Expert Opin Ther Targets       Date:  2020-01-15       Impact factor: 6.902

Review 3.  Chylomicronemia from GPIHBP1 autoantibodies.

Authors:  Kazuya Miyashita; Jens Lutz; Lisa C Hudgins; Dana Toib; Ambika P Ashraf; Wenxin Song; Masami Murakami; Katsuyuki Nakajima; Michael Ploug; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Lipid Res       Date:  2020-09-18       Impact factor: 5.922

Review 4.  The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis.

Authors:  Philip L S M Gordts; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

Review 5.  GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.

Authors:  Stephen G Young; Loren G Fong; Anne P Beigneux; Christopher M Allan; Cuiwen He; Haibo Jiang; Katsuyuki Nakajima; Muthuraman Meiyappan; Gabriel Birrane; Michael Ploug
Journal:  Cell Metab       Date:  2019-07-02       Impact factor: 27.287

6.  Syndecan-1 Mediates Sorting of Soluble Lipoprotein Lipase with Sphingomyelin-Rich Membrane in the Golgi Apparatus.

Authors:  Emma L Sundberg; Yongqiang Deng; Christopher G Burd
Journal:  Dev Cell       Date:  2019-09-19       Impact factor: 12.270

Review 7.  Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.

Authors:  Anna Wolska; Richard L Dunbar; Lita A Freeman; Masako Ueda; Marcelo J Amar; Denis O Sviridov; Alan T Remaley
Journal:  Atherosclerosis       Date:  2017-10-20       Impact factor: 5.162

8.  An upstream enhancer regulates Gpihbp1 expression in a tissue-specific manner.

Authors:  Christopher M Allan; Patrick J Heizer; Yiping Tu; Norma P Sandoval; Rachel S Jung; Jazmin E Morales; Eniko Sajti; Ty D Troutman; Thomas L Saunders; Darren A Cusanovich; Anne P Beigneux; Casey E Romanoski; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2018-12-31       Impact factor: 5.922

Review 9.  Lipoprotein Lipase and Its Regulators: An Unfolding Story.

Authors:  Shuangcheng Alivia Wu; Sander Kersten; Ling Qi
Journal:  Trends Endocrinol Metab       Date:  2020-12-01       Impact factor: 12.015

Review 10.  A Systems View of the Heparan Sulfate Interactome.

Authors:  Alejandro Gómez Toledo; James T Sorrentino; Daniel R Sandoval; Johan Malmström; Nathan E Lewis; Jeffrey D Esko
Journal:  J Histochem Cytochem       Date:  2021-02       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.